Scott D. Kelley
Nessuna posizione attualmente
Storia della carriera di Scott D. Kelley
Precedenti posizioni note di Scott D. Kelley
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| FLEXION THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 11/12/2017 | 31/05/2021 |
| Corporate Officer/Principal | 06/07/2016 | 11/12/2017 | |
| The University of California, San Francisco | Corporate Officer/Principal | 01/01/1990 | 01/01/2000 |
| Sanofi Corp. | Corporate Officer/Principal | - | - |
Aspect Medical Systems, Inc.
 Aspect Medical Systems, Inc. Medical SpecialtiesHealth Technology Aspect Medical Systems, Inc. developed and manufactured anesthesia monitoring system that was called Bispectral (BIS) system. The company was founded in 1987 and was headquartered in Norwood, MA. | Direttore Tecnico/Scientifico/R&S | 01/07/2000 | - |
Formazione di Scott D. Kelley
| The University of California, San Francisco | Doctorate Degree |
| Stanford University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Aspect Medical Systems, Inc.
Aspect Medical Systems, Inc. Medical SpecialtiesHealth Technology Aspect Medical Systems, Inc. developed and manufactured anesthesia monitoring system that was called Bispectral (BIS) system. The company was founded in 1987 and was headquartered in Norwood, MA. | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
| Sanofi Corp. |
- Borsa valori
- Insiders
- Scott D. Kelley
- Esperienza
